Clinical Trial Update: A Phase III Study of Re-Irradiation in Recurrent Glioblastoma [Phase 3]

View source ↗

Summary

A Phase III study evaluating re-irradiation for recurrent glioblastoma has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma

Snippet

Sponsor: AHS Cancer Control Alberta | Conditions: Recurrent Glioblastoma | Phase 3 | Status: WITHDRAWN